[go: up one dir, main page]

CR6467A - INTERRUPTED HORMONE REPLACEMENT THERAPY WITH LOW STROGEN DOSE - Google Patents

INTERRUPTED HORMONE REPLACEMENT THERAPY WITH LOW STROGEN DOSE

Info

Publication number
CR6467A
CR6467A CR6467A CR6467A CR6467A CR 6467 A CR6467 A CR 6467A CR 6467 A CR6467 A CR 6467A CR 6467 A CR6467 A CR 6467A CR 6467 A CR6467 A CR 6467A
Authority
CR
Costa Rica
Prior art keywords
strogen
dose
replacement therapy
hormone replacement
per day
Prior art date
Application number
CR6467A
Other languages
Spanish (es)
Inventor
F Casper Robert
A Shangold Gary
K A Susmanas Militza
Original Assignee
Jencap Rearch Ltd
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jencap Rearch Ltd, Ortho Mcneil Pharm Inc filed Critical Jencap Rearch Ltd
Publication of CR6467A publication Critical patent/CR6467A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA TERAPIA DE REEMPLAZO DE HORMONA, QUE COMPRENDE UNA PLURALIDAD DE DOSIS DIARIAS DE UNA PREPARACION FARMACEUTICA, SIENDO LA DOSIS ADMINISTRADA CONTINUAMENTE Y CONSECUTIVAMENTE EN FASES ALTERNANTES DE TRES DOSIS DIARIAS, UNA FASE DE ACTIVIDAD ESTROGENICA RELATIVAMENTE DOMINANTE QUE COMPRENDE TRES DOSIS DIARIAS DE UNA SUSTANCIA QUE MUESTRA ACTIVIDAD ESTROGENICA EQUIVALENTE A CERCA DE 1 MG POR DIA DE 17B-ESTRADIOL POR DIA, Y UNA FASE PROGESTOGENICA ACTIVA RELATIVAMENTE DOMINANTE DE UNA COMBINACION DE UNA SUSTANCIA MOSTRANDO UNA ACTIVIDAD ESTROGENICA EQUIVALENTE A CERCA DE 1MG POR DIA DE 17B-ESTRADIOL Y UNA SUSTANCIA QUE MUESTRA ACTIVIDAD PROGESTOGENICA EQUIVALENTE A CERCA DE 90 UG DE NORGESTIMATO POR DIAA HORMONE REPLACEMENT THERAPY, WHICH INCLUDES A PLURALITY OF DAILY DOSE OF A PHARMACEUTICAL PREPARATION, BEING THE DOSE ADMINISTERED CONTINUOUSLY AND CONSECUTIVELY IN ALTERNATING PHASES OF THREE DAILY DOSE, A PHASE OF STROGENIC ACTIVITY RELATING TO ONE THREE DIFFERENTLY THAN ONE SHOWS EQUIVALENT STROGEN ACTIVITY NEAR 1 MG PER DAY OF 17B-ESTRADIOL PER DAY, AND A RELATIVELY ACTIVE PROGESTOGENIC PHASE RELATING TO A COMBINATION OF A SUBSTANCE SHOWING A EQUIVALENT STROGEN ACTIVITY NEAR 1MG FOR A DAY OF THREE DAYS SAMPLE EQUIVALENT PROGESTOGEN ACTIVITY NEAR 90 UG NORGESTIMATE PER DAY

CR6467A 2001-09-26 2001-09-26 INTERRUPTED HORMONE REPLACEMENT THERAPY WITH LOW STROGEN DOSE CR6467A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12697001P 2001-09-26 2001-09-26

Publications (1)

Publication Number Publication Date
CR6467A true CR6467A (en) 2003-12-05

Family

ID=51359485

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6467A CR6467A (en) 2001-09-26 2001-09-26 INTERRUPTED HORMONE REPLACEMENT THERAPY WITH LOW STROGEN DOSE

Country Status (1)

Country Link
CR (1) CR6467A (en)
  • 2001

Similar Documents

Publication Publication Date Title
AR029159A1 (en) PHARMACEUTICAL PREPARATION, PACKAGE CONTAINING AND USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT IN HORMONAL REPLACEMENT THERAPY
HRP20070188B1 (en) PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS A CONTRACEPTIC
DE60115029D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES
ES2191329T3 (en) USE OF XANTOFILS IN MEDICINES FOR THE IMPROVEMENT OF THE DURATION OF MUSCLE FUNCTION OR THE TREATMENT OF DISORDERS OR MUSCULAR DISEASES.
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
UA32636C2 (en) Method for reducing cholesterol content in human blood serum
PT693924E (en) PROCESSES FOR THE ADMINISTRATION (IN VIVO) OF BIOLOGICAL AND COMPOSITION SUBSTANCES USED IN THESE PROCESSES
ATE286725T1 (en) NEW ORAL MEDICINAL PREPARATIONS FOR RIVASTIGMINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
DE69505677D1 (en) LIPOSOMAL ADMINISTRATION SYSTEM FOR BIOLOGICALLY ACTIVE SUBSTANCES
UY26372A1 (en) "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM"
ATE224717T1 (en) ORAL MEDICINAL PREPARATIONS CONTAINING A BENZHYDRYLPIPERAZINE AND A CYCLODEXTRIN
EA200401317A1 (en) COMPOSITIONS AND METHODS OF LIPOS DOSING OF CERTAIN DIMENSIONS FOR THE TREATMENT OR PREVENTION OF DISEASE
TR200000369T2 (en) Production of combined pharmaceutical preparations for use in the treatment of rheumatic diseases.
ITMI921831A1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF MICROEMULSIONS OR BIOADHESIVE LIPOSOMIAL DISPERSIONS FOR THE TRANSMUCOSAL ADMINISTRATION OF PEPTIDAL SUBSTANCES AND PHARMACOLOGICALLY ACTIVE PROTEINS
CO5261567A1 (en) USE OF BIOGENIC STROGEN SULFAMATES IN A HORMONE REPLACEMENT THERAPY
DE59914183D1 (en) DISPOSABLE DEVICE FOR A COMPOSITION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
CR6467A (en) INTERRUPTED HORMONE REPLACEMENT THERAPY WITH LOW STROGEN DOSE
BR0107881A (en) Fsh use infertility treatment
MXPA03009447A (en) Single dose aromatase inhibitor for treating infertility.
AR012638A1 (en) USE OF PREGNAN-3-OL-20-ONAS FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO PROVIDE PROGESTATIONAL THERAPY
ATE91890T1 (en) MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM.
US6630149B1 (en) Blister containing a transdermal therapeutic system and a single dose form of administration
BR0010968A (en) Pharmaceutical preparation, pharmaceutical packaging, treatment method and use of an estrogenically active substance and progestogenically active substance in the preparation of a medicine
HUP9800623A2 (en) Application of (+)-o-demethyl-tramadol for production of oral analgesic pharmaceutical compositions
AR109456A2 (en) USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)